Plasma and tissue disposition of mitozolomide in mice.

por Brindley, C. J., Antoniw, P., Newlands, E. S.
Publicado 1986

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours

por de Jonge, M J A, Kaye, S, Verweij, J, Brock, C, Reade, S, Scurr, M, van Doorn, L, Verheij, C, Loos, W, Brindley, C, Mistry, P, Cooper, M, Judson, I
Publicado 2004